Literature DB >> 16877081

Impact of macular edema on visual acuity in uveitis.

Charlotte W T A Lardenoye1, Bram van Kooij, Aniki Rothova.   

Abstract

OBJECTIVE: To investigate the impact of cystoid macular edema (CME) on visual acuity in patients with uveitis.
DESIGN: Cross-sectional study. PARTICIPANTS: The data from 529 patients (842 eyes) with uveitis were analyzed. MAIN OUTCOME MEASURES: We recorded gender and age of the patients, anatomic site and diagnosis of uveitis, associations with systemic diseases, onset and duration of uveitis, presence of CME, best-corrected visual acuity, and the causes of decrease in visual acuity.
RESULTS: Cystoid macular edema was noted in 175 (33%) of all uveitis patients, of whom 77 (44%) had visual acuity of 20/60 or less in at least 1 eye. The mean visual acuity for eyes with CME was significantly worse than for eyes without CME (0.25 vs. 0.4; P = 0.003). Of all uveitis patients, 185 (35%) had visual acuity of 20/60 or less in at least 1 eye, which was caused by CME in 77 (42%) patients. Poor visual acuity in patients with CME was associated with the advanced age of the patients, chronic inflammation, and various specific uveitis entities. The development of visually impaired or blind eyes in patients with panuveitis and intermediate uveitis was caused in most cases by CME (59% and 85%, respectively).
CONCLUSIONS: Cystoid macular edema was a major cause of visual loss in patients with uveitis. The unsatisfactory visual acuity in patients with uveitis underlines the need for improved management of this complication.

Entities:  

Mesh:

Year:  2006        PMID: 16877081     DOI: 10.1016/j.ophtha.2006.03.027

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  64 in total

1.  Treatment of inflammatory macular edema with humanized anti-CD11a antibody therapy.

Authors:  Lisa J Faia; H Nida Sen; Zhuqing Li; Steven Yeh; Keith J Wroblewski; Robert B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

2.  Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis.

Authors:  Jennifer E Thorne; Ebenezer Daniel; Douglas A Jabs; Sanjay R Kedhar; George B Peters; James P Dunn
Journal:  Am J Ophthalmol       Date:  2008-03-05       Impact factor: 5.258

3.  Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.

Authors:  Moncef Khairallah; Sonia Attia; Salim Ben Yahia; Salah Jenzeri; Rim Ghrissi; Bechir Jelliti; Sonia Zaouali; Riadh Messaoud
Journal:  Int Ophthalmol       Date:  2008-03-26       Impact factor: 2.031

4.  Treatment and functional outcome of patients with cystoid macular edema: a single-center experience.

Authors:  Mara Taraborelli; Ilaria Cavazzana; Micaela Fredi; Paolo Airò; Giuseppe Nascimbeni; Angela Tincani; Franco Franceschini
Journal:  Clin Rheumatol       Date:  2014-06-11       Impact factor: 2.980

5.  Vitreous levels of somatostatin in patients with chronic uveitic macular oedema.

Authors:  A Fonollosa; E Coronado; R Catalan; M Gutierrez; C Macia; M A Zapata; N Martinez-Alday; R Simo; J Garcia-Arumi
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

6.  Development of an activity disease score in patients with uveitis (UVEDAI).

Authors:  Esperanza Pato; Mª Auxiliadora Martin-Martinez; Adela Castelló; Rosalía Méndez-Fernandez; Santiago Muñoz-Fernández; Miguel Cordero-Coma; Lucia Martinez-Costa; Elia Valls; Miguel Reyes; Félix Francisco; Mar Esteban; Alex Fonollosa; Fernando Sanchez-Alonso; Cruz Fernández-Espartero; Teresa Diaz-Valle; José Miguel Carrasco; Emma Beltran-Catalán; Marisa Hernández-Garfella; María Victoria Hernández; Laura Pelegrin; Ricardo Blanco; David Diaz-Valle
Journal:  Rheumatol Int       Date:  2016-11-04       Impact factor: 2.631

Review 7.  IL-6 blockade in the management of non-infectious uveitis.

Authors:  Giuseppe Lopalco; Claudia Fabiani; Jurgen Sota; Orso Maria Lucherini; Gian Marco Tosi; Bruno Frediani; Florenzo Iannone; Mauro Galeazzi; Rossella Franceschini; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-05-20       Impact factor: 2.980

8.  Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Authors:  John H Kempen; Mark L Van Natta; Michael M Altaweel; James P Dunn; Douglas A Jabs; Susan L Lightman; Jennifer E Thorne; Janet T Holbrook
Journal:  Am J Ophthalmol       Date:  2015-09-18       Impact factor: 5.258

9.  Aquaporin expression in blood-retinal barrier cells during experimental autoimmune uveitis.

Authors:  Elie Motulsky; Philippe Koch; Sarah Janssens; Maité Liénart; Anne-Marie Vanbellinghen; Nargis Bolaky; Chi-Chao Chan; Laure Caspers; Maria-Dolores Martin-Martinez; Heping Xu; Christine Delporte; François Willermain
Journal:  Mol Vis       Date:  2010-04-03       Impact factor: 2.367

10.  Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil.

Authors:  Piergiorgio Neri; Cesare Mariotti; Luca Cimino; Lucia Mercanti; Alfonso Giovannini
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.